Laboratory:Akiruno
- TOP
- research test
- other specific tests
Laboratory:Akiruno
○other specific tests
TEST NAME |
SPECIMEN REQUIREMENT (mL) |
CONTAINER | CAP COLOR | STORE TEMPERATURE (STABILITY) |
TURNAROUND TIME (DAY) |
METHODOLOGY | REFERENCE RANGE (UNIT) |
---|---|---|---|---|---|---|---|
Prostaglandin E major metabolite(PGE-MUM)
|
Partial urine
2.0 |
A00 |
(21 days) |
2-6 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
Concentration (ng/mL) Conversion value 30.2 or less (Cutoff value)(μg/gCr) |
|
Nitrite/nitrate ion
|
Serum
0.3 |
S09 ↓ A00 |
|
Please contact us in advance. |
HPLC HPLC (High performance liquid chromatography) |
Nitrite ion 1 or less Nitrate ion 10-71 (μmol/L) |
|
Leptin
|
Serum
0.5 |
S09 ↓ A00 |
|
3-16 |
RIA2 antibody method RIA (Radio immunoassay) |
(ng/mL) | |
Total tau protein (AD)
|
Cerebrospinal fluid
2.5 |
XR5 |
(15 days) |
3-9 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
146-410(pg/mL) | |
High molecular weight adiponectin [CLEIA]
|
Serum
0.3 |
S09 ↓ A00 |
(28 days) |
2-8 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
(μg/mL) | |
|
tissue
250mg |
ARR |
|
12-17 | Pyrosequencing method | (%) | |
|
Plasma (DPP-IV inhibitor added during blood collection) 0.5 |
PAP ↓ A00 |
(28 days) |
Please confirm in advance |
ELISA ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate. |
(pmol/L) | |
|
Plasma (DPP-IV inhibitor added during blood collection) 0.5 |
PAP ↓ A00 |
(28 days) |
5-11 |
ELISA ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate. |
9.2-44.8(reference value)(pg/mL) | |
|
Plasma
0.3 |
PC2 ↓ A00 |
|
Please confirm in advance | Synthetic substrate method | (%) | |
|
bone marrow aspirate
|
H00 |
|
Please confirm in advance |
Flow cytometry(FCM) Flow cytometry |
(%) | |
|
Plasma 0.5 |
PN2,PN5 ↓ A00 |
(60 days) |
Please confirm in advance |
ELISA ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate. |
(pmol/L) | |
|
Serum
0.5 |
S09 ↓ A00 |
(28 days) |
2-4 |
ECLIA ECLIA (Electro chemiluminescence immunoassay) |
See below | |
|
Partial urine
2.0 |
U00 |
(28 days) |
Please confirm in advance |
ELISA ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate. |
Concentration (ng/mL) Conversion ratio (ng/mg・CRE) |
|
|
Partial urine
0.3 |
A00 |
(21 days) |
Please confirm in advance |
RIA2 antibody method RIA (Radio immunoassay) |
Concentration (ng/mL) Conversion ratio (μg/g・CRE) | |
|
Plasma (DPP-IV inhibitor added during blood collection) 0.5 |
PAP ↓ A00 |
(28 days) |
Please confirm in advance |
ELISA ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate. |
(pmol/L) | |
|
Plasma (DPP-IV inhibitor added during blood collection) 0.5 |
PAP ↓ A00 |
(28 days) |
Please confirm in advance | Pretreatment: Solid phase extraction Measurement method: ELISA | (pmol/L) | |
|
Plasma (DPP-IV inhibitor added during blood collection) 0.5 |
PAP ↓ A00 |
(2 months) |
Please confirm in advance | Pretreatment: Solid phase extraction Measurement method: ELISA | (pmol/L) | |
|
Plasma (DPP-IV inhibitor added during blood collection) 0.5 |
PAP ↓ A00 |
(28 days) |
Please confirm in advance |
ELISA ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate. |
(pmol/L) | |
|
Serum
0.3 |
S09 ↓ A00 |
|
4-10 |
ELISA ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate. |
(ng/mL) | |
|
Paraffin section
|
A00 |
|
Please confirm in advance |
Flow cytometry(FCM) Flow cytometry |
(%) | |
|
Peripheral blood (heparin added)
10.0 |
PH5 |
|
Please confirm in advance |
Flow cytometry(FCM) Flow cytometry |
||
|
Serum
0.5 |
S09 ↓ A00 |
(28 days) |
2-4 |
ELISA ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate. |
(ng/mL) | |
|
tissue
|
A00 |
(-70℃) |
Please confirm in advance |
Flow cytometry(FCM) Flow cytometry |
(%) | |
|
Peripheral blood (heparin added)
10.0 |
PH5 |
|
Please confirm in advance |
Flow cytometry(FCM) Flow cytometry |
(%) | |
|
Plasma 1.0 |
PN5 ↓ A00 |
(-70℃) |
10-14 |
MALDI-TOF-MS MALDI-TOF-MS |
||
|
tissue
250mg |
ARR |
|
12-17 | Pyrosequencing method | (%) |